Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HSII
601
DELISTED
Heidrick & Struggles
HSII
| $30.6M | 0.03% |
1,416,002
+141,602
| +11% | +$3.12M |
2013 Q2
28 quarters
|
|
602
Micron Technology
MU
$1.16T
| $30.6M | 0.03% |
593,736
-55,800
| -9% | -$2.63M |
2018 Q4
6 quarters
|
|
603
CBRE Group
CBRE
$37.9B
| $30.5M | 0.03% |
673,700
+435,800
| +183% | +$18.8M |
2020 Q1
1 quarter
|
|
604
Emergent Biosolutions
EBS
$362M
| $30.4M | 0.03% |
384,624
-238,377
| -38% | -$17.8M |
2013 Q2
28 quarters
|
|
605
International Paper
IP
$17B
| $30.4M | 0.03% |
911,750
+541,411
| +146% | +$17.2M |
2020 Q1
1 quarter
|
|
606
American Eagle Outfitters
AEO
$3.04B
| $30.4M | 0.03% |
2,787,711
+139,377
| +5% | +$1.32M |
2018 Q2
8 quarters
|
|
607
AtriCure
ATRC
$2.84B
| $30.3M | 0.03% |
673,475
+138,975
| +26% | +$6.05M |
2017 Q3
11 quarters
|
|
608
Armstrong World Industries
AWI
$6.84B
| $30.2M | 0.03% |
386,800
-324,500
| -46% | -$24.6M |
2017 Q1
13 quarters
|
|
609
Kite Realty
KRG
$4.79B
| $30.1M | 0.03% |
2,611,399
-615,799
| -19% | -$6.18M |
2018 Q2
8 quarters
|
|
610
Southside Bancshares
SBSI
$900M
| $30.1M | 0.03% |
1,084,185
-4,361
| -0.4% | -$124K |
2013 Q2
28 quarters
|
|
611
Cognizant
CTSH
$26.7B
| $30M | 0.03% |
528,565
-682,143
| -56% | -$36.6M |
2019 Q3
3 quarters
|
|
612
Paycom
PAYC
$10.5B
| $30M | 0.03% |
96,950
-38,200
| -28% | -$10.2M |
2020 Q1
1 quarter
|
|
|
AHRT
613
AH Realty Trust
AHRT
$451M
| $30M | 0.03% |
3,015,809
-838,600
| -22% | -$7.6M |
2013 Q4
26 quarters
|
|
|
PRMW
614
DELISTED
Primo Water Corporation
PRMW
| $30M | 0.03% |
2,178,360
-323,083
| -13% | -$3.62M |
2013 Q2
28 quarters
|
|
615
VF Corp
VFC
$5.9B
| $29.9M | 0.03% |
+491,200
| New | +$28.6M |
2020 Q2
0 quarters
|
|
616
Waterstone Financial
WSBF
$350M
| $29.8M | 0.03% |
2,009,544
-57,400
| -3% | -$813K |
2013 Q2
28 quarters
|
|
617
PennyMac Financial
PFSI
$3.11B
| $29.8M | 0.03% |
713,022
-259,927
| -27% | -$8.23M |
2019 Q1
5 quarters
|
|
618
Grupo Aeroportuario del Sureste
ASR
$6.95B
| $29.7M | 0.03% |
264,183
-19,500
| -7% | -$2.07M |
2013 Q2
28 quarters
|
|
619
Materion
MTRN
$5.84B
| $29.6M | 0.03% |
481,411
-55,700
| -10% | -$2.82M |
2017 Q4
10 quarters
|
|
620
ManpowerGroup
MAN
$2.45B
| $29.4M | 0.03% |
428,352
+415,700
| +3,286% | +$28.4M |
2020 Q1
1 quarter
|
|
621
Capital One
COF
$122B
| $29.4M | 0.03% |
470,435
+63,336
| +16% | +$3.94M |
2019 Q3
3 quarters
|
|
622
Revvity
RVTY
$17.2B
| $29.4M | 0.03% |
+300,100
| New | +$27.4M |
2020 Q2
0 quarters
|
|
623
Teradata
TDC
$2.84B
| $29.4M | 0.03% |
1,415,219
-308,568
| -18% | -$6.71M |
2014 Q4
22 quarters
|
|
624
Howmet Aerospace
HWM
$89.8B
| $29.3M | 0.03% |
1,850,400
+170,587
| +10% | +$2.24M |
2019 Q1
5 quarters
|
|
625
argenx
ARGX
$51.9B
| $29.3M | 0.03% |
130,014
+78,641
| +153% | +$14M |
2019 Q1
5 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.